Loading clinical trials...
Loading clinical trials...
Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use: a Multicentre, Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial
Conditions
Interventions
Brevicillin® gocce (Bifidobacterium breve PRL2020)
Placebo (matching oil drops)
Start Date
December 1, 2025
Primary Completion Date
April 30, 2026
Completion Date
May 29, 2026
Last Updated
November 24, 2025
NCT03181516
NCT06665503
NCT05607056
NCT04212403
NCT00182429
NCT02993419
Lead Sponsor
Liaquat University of Medical & Health Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions